Type III Secretion System Genotypes and Biofilm-Forming Capacity of Pseudomonas aeruginosa Bloodstream Isolates: An Exploratory Analysis of the exoU-Fluoroquinolone Association.
- 1Department of Medical Microbiology, Denizli State Hospital, Merkezefendi, 20010 Denizli, Turkey.
- 2Department of Medical Microbiology, Faculty of Medicine, Pamukkale University, Pamukkale, 20160 Denizli, Turkey.
Abstract
The pathogenicity of Pseudomonas aeruginosa in bloodstream infection is shaped by biofilm formation and the type III secretion system (T3SS). We characterised the biofilm-associated and T3SS genotypes of 100 non-duplicate bloodstream isolates and tested whether either trait co-segregates with antimicrobial resistance. Biofilm was assessed by Congo red agar (CRA) and the quantitative microtiter plate (MTP) assay; biofilm-associated (pslA, pelA, ppyR) and T3SS effector (exoS, exoY, exoT, exoU) genes by conventional PCR; and susceptibility by an automated system interpreted with EUCAST criteria. Biofilm was detected in 84% of isolates by MTP and 25% by CRA (Cohen's κ = 0.16). pslA was present in 100%, pelA and ppyR in 99%; all isolates carried exoY and exoT, exoS was found in 88% and exoU in 27%. Multidrug resistance was 15%. Biofilm phenotype was unrelated to resistance. In contrast, levofloxacin resistance was more frequent among exoU-positive isolates (29.6% vs. 9.6%; p = 0.024), and this association survived adjustment for biofilm phenotype and hospital unit in multivariable analysis (adjusted OR 3.90, 95% CI 1.20-12.67). However, the association did not remain significant after correction for multiple comparisons or after excluding exoS/exoU co-positive isolates. The exoU-fluoroquinolone relationship is therefore presented as an exploratory, hypothesis-generating finding that requires confirmation by reference susceptibility testing and clonal characterisation.
Related
- Expression of ExsA in trans Confers Type III Secretion System-Dependent Cytotoxicity on Noncytotoxic Pseudomonas aeruginosa Cystic Fibrosis Isolates
- Role of manganese superoxide dismutase in a mucoid isolate of Pseudomonas aeruginosa: adaptation to oxidative stress
- Cell Death of Human Polymorphonuclear Neutrophils Induced by a Pseudomonas aeruginosa Cystic Fibrosis Isolate Requires a Functional Type III Secretion System
- Mechanical compression activates cAMP signaling in Pseudomonas aeruginosa
- Pseudomonas aeruginosa Cystic Fibrosis Isolates Induce Rapid, Type III Secretion-Dependent, but ExoU-Independent, Oncosis of Macrophages and Polymorphonuclear Neutrophils
BibTeX
@article{iren2026type,
title = {{Type III Secretion System Genotypes and Biofilm-Forming Capacity of Pseudomonas aeruginosa Bloodstream Isolates: An Exploratory Analysis of the exoU-Fluoroquinolone Association.}},
author = {Hazel Malaş İren and Ergun Mete},
journal = {Pathogens (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/pathogens15101052},
url = {https://europepmc.org/article/MED/42931204},
note = {CC BY},
}
RIS
TY - JOUR
TI - Type III Secretion System Genotypes and Biofilm-Forming Capacity of Pseudomonas aeruginosa Bloodstream Isolates: An Exploratory Analysis of the exoU-Fluoroquinolone Association.
AU - Hazel Malaş İren
AU - Ergun Mete
PY - 2026
DA - 2026/10/04
JO - Pathogens (Basel, Switzerland)
DO - 10.3390/pathogens15101052
UR - https://europepmc.org/article/MED/42931204
AB - The pathogenicity of Pseudomonas aeruginosa in bloodstream infection is shaped by biofilm formation and the type III secretion system (T3SS). We characterised the biofilm-associated and T3SS genotypes of 100 non-duplicate bloodstream isolates and tested whether either trait co-segregates with antimicrobial resistance. Biofilm was assessed by Congo red agar (CRA) and the quantitative microtiter plate (MTP) assay; biofilm-associated (pslA, pelA, ppyR) and T3SS effector (exoS, exoY, exoT, exoU) genes by conventional PCR; and susceptibility by an automated system interpreted with EUCAST criteria. Biofilm was detected in 84% of isolates by MTP and 25% by CRA (Cohen's κ = 0.16). pslA was present in 100%, pelA and ppyR in 99%; all isolates carried exoY and exoT, exoS was found in 88% and exoU in 27%. Multidrug resistance was 15%. Biofilm phenotype was unrelated to resistance. In contrast, levofloxacin resistance was more frequent among exoU-positive isolates (29.6% vs. 9.6%; p = 0.024), and this association survived adjustment for biofilm phenotype and hospital unit in multivariable analysis (adjusted OR 3.90, 95% CI 1.20-12.67). However, the association did not remain significant after correction for multiple comparisons or after excluding exoS/exoU co-positive isolates. The exoU-fluoroquinolone relationship is therefore presented as an exploratory, hypothesis-generating finding that requires confirmation by reference susceptibility testing and clonal characterisation.
SN - 2076-0817
ER -